France Drug Delivery Devices Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

France represents one of the largest national drug delivery devices markets in Western Europe, with a 2025 valuation around $6.9 billion. The sector covers a wide range of product categories including injection systems, pulmonary delivery devices, nasal sprays, transdermal patches, and implantable drug delivery systems. As a core component of France's broader healthcare technology landscape, the market benefits from the country's established pharmaceutical manufacturing base and universal healthcare coverage that supports broad patient access.

• •Market valued at approximately $6.9 billion in 2025; projected to reach roughly $10.6-11.5 billion by 2030-2031 depending on methodology
• •Growth rate consistently reported at approximately 8.9-9.0% CAGR across industry analyses
• •France is the second-largest economy in Western Europe with a mature healthcare infrastructure supporting medical device adoption

The rising prevalence of chronic diseases such as diabetes, asthma, and cardiovascular conditions across France's aging population is a primary catalyst for market expansion. The expanding pipeline of biologic and biosimilar drugs, which typically require specialized delivery mechanisms like autoinjectors and prefilled syringes, further amplifies demand. Additionally, regulatory and reimbursement support from French health authorities for innovative delivery technologies, combined with patient and clinician preference for home-based self-administration, accelerates adoption rates.

• •Aging demographic profile with growing incidence of chronic conditions driving sustained demand for drug delivery devices
• •Biologic drug approvals increasingly rely on advanced delivery systems such as wearable injectors and pen injectors
• •Injectable drug delivery segment in France projected at a notably high 23.21% CAGR over 2025-2032, indicating strong sub-segment momentum

Within the French market, the injectable drug delivery segment is one of the fastest-growing sub-sectors, buoyed by diabetes management devices, biologic self-injection systems, and vaccine delivery technologies. The pulmonary and aerosol delivery segment is also expanding rapidly, with France's aerosol drug delivery market forecast at a 13.5% CAGR through 2030. Taken together, these device-intensive segments significantly outpace the broader European drug delivery market, which is valued at roughly $253.7 billion in 2025 and growing at a 5.0% CAGR.

• •Aerosol drug delivery devices in France projected to grow at 13.5% CAGR from 2025 to 2030, reaching approximately $2.83 billion
• •Injectable delivery segment expected to achieve approximately 23.21% CAGR through 2032, reflecting intense innovation and adoption
• •The overall European drug delivery devices market reached approximately $123.4 billion in 2025, placing France as a major contributor within the regional context

What are the recent trends and outlook?

Connected and digital drug delivery devices are reshaping the competitive and technological landscape, with smart inhalers, connected injectors, and dose-tracking platforms gaining traction in France's value-driven healthcare system. Sustainability pressures are influencing device design, with manufacturers exploring refillable systems and reduced plastic content to align with European regulatory trends. The long-term outlook remains strongly positive, with the market's 9% growth trajectory expected to continue through the early 2030s as biologic proliferation, homecare expansion, and digital health integration sustain device demand across France's healthcare ecosystem.

• •Connected drug delivery devices and digital adherence platforms are emerging as key differentiators in the French market
• •Sustainability and circular economy pressures are prompting shifts toward reusable and recyclable device architectures
• •Market forecast to maintain approximately 8.9-9.0% annual growth through 2030-2031, supported by sustained biologic pipeline expansion